EyePoint Pharmaceuticals to supply products for 9 million veterans, federal workers

Listen

Specialty biopharmaceutical company EyePoint Pharmaceuticals signed an agreement with the Department of Veteran Affairs to add two of its products to the federal supply schedule.

Through the agreement, EyePoint's Yutiq and Dexycu products for eye surgery will be available to 9 million VA beneficiaries and federal employees. The contract will last five years.

“This new agreement with the VA further extends the commercial reach of Dexycu and Yutiq to patients suffering from ocular diseases in areas of high unmet medical need,” said Nancy Lurker, president and CEO of Watertown-Mass.-based EyePoint Pharmaceuticals.

© Copyright ASC COMMUNICATIONS 2021. Interested in LINKING to or REPRINTING this content? View our policies by clicking here.

 

Featured Webinars

Featured Whitepapers